Taragenyx

About:

Regenerating orthopedic and dental implant design to help patients heal faster with far less pain.

Website: http://www.taragenyx.com

Twitter/X: taragenyx

Top Investors: Scottish Enterprise, SBRI Healthcare, Lancaster Capital

Description:

A medical device company developing a broad pipeline of bio-passive, bio active and bio regenerative coatings for orthopaedic and dental implants. Taragenyx incorporate active pharmaceuticals and biologics into the coating of the implant surface itself giving the ability to release compounds locally from the implant post-operatively. Thereby bringing the potential to; accelerate bone growth, drive faster healing and reduce the incidence of infection and pain.

Total Funding Amount:

1.13M GBP

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Glasgow, Glasgow City, United Kingdom

Founded Date:

2010-08-01

Contact Email:

hello(AT)taragenyx.com

Founders:

Iain McDougall, Raman Bedi

Number of Employees:

11-50

Last Funding Date:

2015-08-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai